Jecure Therapeutics Strengthens Management Team
Gretchen Bain Joins as VP of Biology
DEC 14, 2017
Jecure Therapeutics, a biotechnology company with novel drug discovery programs targeting non-alcoholic steatohepatitis (NASH) and fibrosis, today announced that Gretchen Bain, Ph.D., has joined the company as its Vice President of Biology.
Read the full story here.